- In November 2023, QIAGEN introduced a comprehensive Sample to Insight workflow specifically designed for microbiome research, which is expected to significantly accelerate research workflows. This includes whole genome metagenomics library preparation, DNA extraction kits, and bioinformatics analysis, streamlining the research process and improving efficiency
- In August 2023, Ampath announced the opening of a reference laboratory in Gurgaon, marking a pivotal expansion for the company. This facility offers a broad range of diagnostic tests, including clinical biochemistry, haematology, microbiology, immunology, and more, supporting the growth of the diagnostic services market
- In July 2023, Eurofins Scientific revealed the expansion of its microbial laboratory in Texas, which is set to enhance its capacity and accelerate the growth of the microbial identification market over the forecast period. The expansion is expected to improve service delivery and capacity
- In May 2023, Merck KGaA invested approximately USD 38.35 million to enhance biosafety testing at its facilities in Glasgow and Stirling, Scotland. This investment is aimed at boosting the safety, efficacy, and regulatory compliance of pharmaceuticals during drug development and manufacturing
- In May 2023, Charles River launched Next Generation Sequencing Services, Accugenix NGS, focusing on bacterial and fungal identification. This service is anticipated to provide essential microbial control information to pharmaceutical manufacturers, advancing microbial identification and control in drug production
